Enveric Biosciences Inc
Change company Symbol lookup
Select an option...
ENVB Enveric Biosciences Inc
OTLK Outlook Therapeutics Inc
PBHC Pathfinder Bancorp Inc (MARYLAND)
CMA Comerica Inc
IART Integra Lifesciences Holdings Corp
ARKW.SO ARK Next Generation Internet ETF
AGNC Agnc Investment Corp
HCA HCA Healthcare Inc
LGHL Lion Group Holding Ltd
IVA Inventiva SA
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Enveric Biosciences, Inc. is a biotechnology company. The Company is engaged in the development of novel small-molecule therapeutics for the treatment of anxiety, depression and addiction disorders. The Company through Psybrary has created a robust intellectual property (IP) portfolio of New Chemical Entities (NCEs) for specific mental health indications or physical ailments. The Company's lead program, EB-373, is a next-generation prodrug of psilocin, the active metabolite of psilocybin. EB-373 is a drug candidate from the EVM201 Series advancing through preclinical development for the treatment of anxiety disorders. The Company is also advancing its third generation of therapeutics, the EVM301 Series, that eliminates the psychedelic experience and removes unwanted effects, reducing safety concerns, and hence offering a novel and holistic approach for treating central nervous system disorders.

Postmarket

Last Trade
Delayed
$2.55
0.01 (0.39%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$2.54
Day's Change
-0.16 (-5.93%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
2.71
Day's Low
2.26
Volume
(Below Average)
Volume:
34,646

10-day average volume:
42,395
34,646
  • Prev Close
    2.70
  • Today's Open
    2.59
  • Day's Range
    2.26-2.71
  • Avg Vol (10-day)
    42.4K
  • Last (time)
    3:59p ET 10/04/23
  • Last (size)
    1
  • 52-Wk Range
    1.30 - 6.98
    LowHigh
  • (04/11/23 - 05/24/23)
    95.38%
  • 137.7%
  • Market Cap
    5.5M
  • Shares Outstanding
    2.2M
  • -11.02
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.9
  • 8.56
  • (% of float 09/15/23)
    1.25

Latest News

October 03, 2023
8:00 am ET
BusinessWire
September 27, 2023
8:01 am ET
BusinessWire
September 20, 2023
8:00 am ET
BusinessWire
September 18, 2023
8:00 am ET
BusinessWire
September 11, 2023
8:00 am ET
BusinessWire
September 05, 2023
8:00 am ET
BusinessWire
August 30, 2023
8:01 am ET
BusinessWire
August 28, 2023
11:04 am ET
BusinessWire
8:00 am ET
BusinessWire
August 24, 2023
8:00 am ET
Globe Newswire
August 21, 2023
8:00 am ET
BusinessWire
August 14, 2023
8:00 am ET
BusinessWire
July 24, 2023
8:00 am ET
BusinessWire
July 17, 2023
8:00 am ET
BusinessWire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.